Assessment of direct costs attributed to the clinical management of children with inflammatory bowel disease in New Zealand
There was wide variation in annual per-patient costs for IBD management in this group with a consistent cost driver being biologic associated expenditure. This data contributes to the wider evidence base that drug costs are the primary driver of hospital care expenditure.
Authors
- Chris Frampton (ORCID: https://orcid.org/0000-0003-0603-5661)
- Andrew S. Day (ORCID: https://orcid.org/0000-0003-2290-7386)
- Angharad Vernon‐Roberts (ORCID: https://orcid.org/0000-0001-9402-4959)
Institutions
- University of Otago (NZ)
Publication Details
- Journal
- Journal of Pediatric Gastroenterology and Nutrition
- Published
- 2025-10-22
- DOI
- https://doi.org/10.1002/jpn3.70228
- Primary Topic
- Inflammatory Bowel Disease
- Type
- article
- Field-Weighted Citation Impact
- 0.00